Taurus Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $1.03M | Sell |
40,462
-2,463
| -6% | -$64.5K | 0.1% | 55 |
|
|
2024
Q4 | $1.14M | Sell |
42,925
-2,755
| -6% | -$74.7K | 0.11% | 53 |
|
|
2024
Q3 | $1.32M | Buy |
45,680
+680
| +2% | +$19.8K | 0.13% | 49 |
|
|
2024
Q2 | $1.26M | Sell |
45,000
-5,020
| -10% | -$138K | 0.13% | 49 |
|
|
2024
Q1 | $1.39M | Sell |
50,020
-2,583
| -5% | -$71.7K | 0.14% | 48 |
|
|
2023
Q4 | $1.51M | Sell |
52,603
-600
| -1% | -$18.1K | 0.16% | 46 |
|
|
2023
Q3 | $1.76M | Sell |
53,203
-1,400
| -3% | -$49.5K | 0.21% | 45 |
|
|
2023
Q2 | $2M | Sell |
54,603
-2,000
| -4% | -$77.8K | 0.23% | 45 |
|
|
2023
Q1 | $2.31M | Sell |
56,603
-667
| -1% | -$28.8K | 0.28% | 45 |
|
|
2022
Q4 | $2.93M | Hold |
57,270
| – | – | 0.37% | 43 |
|
|
2022
Q3 | $2.51M | Sell |
57,270
-6,806
| -11% | -$331K | 0.34% | 42 |
|
|
2022
Q2 | $3.36M | Sell |
64,076
-2,175
| -3% | -$111K | 0.41% | 40 |
|
|
2022
Q1 | $3.43M | Sell |
66,251
-1,646
| -2% | -$85.4K | 0.35% | 39 |
|
|
2021
Q4 | $4.01M | Sell |
67,897
-1,616
| -2% | -$80.1K | 0.38% | 37 |
|
|
2021
Q3 | $2.99M | Sell |
69,513
-123
| -0.2% | -$5.45K | 0.31% | 40 |
|
|
2021
Q2 | $2.73M | Sell |
69,636
-1,800
| -3% | -$70K | 0.28% | 41 |
|
|
2021
Q1 | $2.59M | Sell |
71,436
-3,101
| -4% | -$110K | 0.3% | 42 |
|
|
2020
Q4 | $2.74M | Sell |
74,537
-51,641
| -41% | -$1.89M | 0.33% | 40 |
|
|
2020
Q3 | $4.39M | Sell |
126,178
-1,897
| -1% | -$66.5K | 0.54% | 39 |
|
|
2020
Q2 | $3.97M | Buy |
128,075
+2,688
| +2% | +$91.3K | 0.55% | 38 |
|
|
2020
Q1 | $3.88M | Sell |
125,387
-236,809
| -65% | -$8.07M | 0.64% | 37 |
|
|
2019
Q4 | $13.5M | Sell |
362,196
-7,896
| -2% | -$281K | 1.76% | 26 |
|
|
2019
Q3 | $12.6M | Sell |
370,092
-1,000
| -0.3% | -$36.4K | 1.79% | 26 |
|
|
2019
Q2 | $15.3M | Sell |
371,092
-3,278
| -0.9% | -$130K | 2.08% | 22 |
|
|
2019
Q1 | $15.1M | Sell |
374,370
-6,107
| -2% | -$245K | 2.11% | 19 |
|
|
2018
Q4 | $15.8M | Buy |
380,477
+474
| +0.1% | +$19.7K | 2.52% | 14 |
|
|
2018
Q3 | $15.9M | Sell |
380,003
-1,107
| -0.3% | -$42.6K | 2.15% | 18 |
|
|
2018
Q2 | $13.1M | Sell |
381,110
-895
| -0.2% | -$30.6K | 1.92% | 21 |
|
|
2018
Q1 | $12.9M | Buy |
382,005
+4,185
| +1% | +$144K | 1.94% | 21 |
|
|
2017
Q4 | $13M | Buy |
377,820
+2,108
| +0.6% | +$71.9K | 1.91% | 21 |
|
|
2017
Q3 | $12.7M | Sell |
375,712
-1,765
| -0.5% | -$56.7K | 1.98% | 21 |
|
|
2017
Q2 | $12M | Sell |
377,477
-1,977
| -0.5% | -$62.3K | 1.88% | 19 |
|
|
2017
Q1 | $12.3M | Sell |
379,454
-109,479
| -22% | -$3.45M | 2.02% | 20 |
|
|
2016
Q4 | $15.1M | Sell |
488,933
-24,366
| -5% | -$744K | 2.73% | 8 |
|
|
2016
Q3 | $16.5M | Sell |
513,299
-2,324
| -0.5% | -$77.7K | 2.98% | 5 |
|
|
2016
Q2 | $17.2M | Sell |
515,623
-6,339
| -1% | -$202K | 3.03% | 5 |
|
|
2016
Q1 | $14.7M | Buy |
521,962
+5,217
| +1% | +$149K | 2.72% | 10 |
|
|
2015
Q4 | $15.8M | Buy |
516,745
+2,853
| +0.6% | +$89.8K | 2.97% | 5 |
|
|
2015
Q3 | $15.3M | Buy |
513,892
+40,969
| +9% | +$1.31M | 2.96% | 3 |
|
|
2015
Q2 | $15M | Sell |
472,923
-3,795
| -0.8% | -$124K | 2.74% | 4 |
|
|
2015
Q1 | $15.7M | Sell |
476,718
-1,634
| -0.3% | -$51.9K | 2.94% | 4 |
|
|
2014
Q4 | $14.1M | Sell |
478,352
-4,479
| -0.9% | -$128K | 2.53% | 4 |
|
|
2014
Q3 | $13.5M | Buy |
482,831
+23,367
| +5% | +$656K | 2.63% | 3 |
|
|
2014
Q2 | $12.9M | Buy |
459,464
+67,487
| +17% | +$1.92M | 2.5% | 4 |
|
|
2014
Q1 | $11.9M | Buy |
391,977
+19,700
| +5% | +$587K | 2.47% | 5 |
|
|
2013
Q4 | $10.8M | Sell |
372,277
-580
| -0.2% | -$16.9K | 2.23% | 7 |
|
|
2013
Q3 | $10.2M | Sell |
372,857
-5,586
| -1% | -$152K | 2.35% | 5 |
|
|
2013
Q2 | $10.1M | Buy |
+378,443
| New | +$10.5M | 2.38% | 6 |
|
Other funds holding PFE
TIM
Taurus Asset Management's PFE Position: Q1 2025 in Review
Taurus Asset Management reduced its Pfizer (PFE) stake by 5.7% in Q1 2025, selling an estimated $64.5K and leaving 40,462 shares worth $1.03M. The position accounts for 0.1% of the portfolio, ranked #55.
Taurus Asset Management first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $17.2M in Q2 2016. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Taurus Asset Management held 40,462 shares of Pfizer worth $1.03M as of Q1 2025.
- Taurus Asset Management sold 2,463 Pfizer shares in Q1 2025, an estimated $64.5K.
- Pfizer made up 0.1% of Taurus Asset Management's portfolio in Q1 2025, its #55 holding.
- Taurus Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- Taurus Asset Management's Pfizer position peaked at $17.2M in Q2 2016.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Taurus Asset Management's 13F filing for Q1 2025, filed 13 May 2025.